SCHEMBL4367765

SCHEMBL4367765

CC(OC(=O)O)OC(=O)O

nearest known ligand 0.41

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.40
TP53 P04637 1/20 0.39
HCAR2 Q8TDS4 1/20 0.36
MMP1 P03956 1/20 0.32
MMP2 P08253 1/20 0.32
MMP3 P08254 1/20 0.32
MMP9 P14780 1/20 0.32
MMP13 P45452 1/20 0.32
SLC7A5 Q01650 1/20 0.32
FFAR3 O14843 1/20 0.31
LCK P06239 1/20 0.31
FYN P06241 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethylene SCHEMBL687838 0.94 TSHR (0.36) TSHRTP53HCAR2MMP1MMP2
SCHEMBL3814641 0.88 TSHR (0.52) TSHRTP53FFAR3LCKFYN
SCHEMBL5986607 0.88 TSHR (0.52) TSHRTP53FFAR3LCKFYN
SCHEMBL2473038 0.86 TSHR (0.32) TSHRTP53HCAR2
SCHEMBL1833108 0.84
SCHEMBL19387187 0.84
SCHEMBL10349931 0.80 TSHR (0.43) TSHRTP53HCAR2
SCHEMBL5435402 0.80 TSHR (0.43) TSHR
SCHEMBL1936262 0.79 TSHR (0.40) TSHRTP53HCAR2MMP1MMP2
SCHEMBL36671 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12630492-B2 Cannabinoid derivatives CANOPY GROWTH CORPORATION (CA) 2026-05-19 US claimed
US-20220267239-A1 CANNABINOID DERIVATIVES JGB COLLATERAL LLC 2022-08-25 US claimed
EP-3994114-A1 CANNABINOID DERIVATIVES Canopy Growth Corporation (CA) 2022-05-11 EP claimed
EP-1636870-B1 STACKED-TYPE LITHIUM-ION RECHARGEABLE BATTERY BYD CO LTD (CN) 2013-04-10 EP claimed
US-7618736-B2 Stacked-type lithium-ion rechargeable battery BYD COMPANY LIMITED (CN) 2009-11-17 US claimed
EP-1636870-A4 STACKED-TYPE LITHIUM-ION RECHARGEABLE BATTERY BYD CO LTD (CN) 2008-05-28 EP claimed
EP-1636870-A1 STACKED-TYPE LITHIUM-ION RECHARGEABLE BATTERY Byd Company Limited (CN) 2006-03-22 EP claimed
WO-2004114452-A1 STACKED-TYPE LITHIUM-ION RECHARGEABLE BATTERY BYD COMPANY LIMITED (CN) 2004-12-29 WO claimed
US-20040258986-A1 Stacked-type lithium-ion rechargeable battery BYD AMERICA CORPORATION 2004-12-23 US claimed
US-12630492-B2 Cannabinoid derivatives CANOPY GROWTH CORPORATION (CA) 2026-05-19 US disclosed
EP-4571888-A1 BINDER, ELECTRODE SHEET, SECONDARY BATTERY, AND ELECTRICAL APPARATUS Contemporary Amperex Technology (Hong Kong) Limited (HK) 2025-06-18 EP disclosed
US-20250149625-A1 LITHIUM-ION BATTERY AND ELECTRIC APPARATUS CONTEMPORARY AMPEREX TECHNOLOGY (HONG KONG) LIMITED (CN) 2025-05-08 US disclosed
US-20250070178-A1 BINDER, ELECTRODE PLATE, SECONDARY BATTERY, AND ELECTRIC APPARATUS CONTEMPORARY AMPEREX TECHNOLOGY (HONG KONG) LIMITED (CN) 2025-02-27 US disclosed
US-20250070189-A1 NEGATIVE ELECTRODE PLATE AND PREPARATION METHOD THEREOF, SECONDARY BATTERY, AND ELECTRIC APPARATUS CONTEMPORARY AMPEREX TECHNOLOGY (HONG KONG) LIMITED (CN) 2025-02-27 US disclosed
CN-1479390-A Manufacturing method of closed cell and closed cell 三洋电机株式会社 2004-03-03 CN disclosed
CN-1132258-C method for manufacturing sealed battery and sealed battery SANYO ELECTRIC CO.,LTD. (JP) 2003-12-24 CN disclosed
CN-1404496-A Organic polymer and novel polymerizable compound MITSUI CHEMICALS INC (JP) 2003-03-19 CN disclosed
CN-1285956-A method for manufacturing sealed battery and sealed battery SANYO ELECTRIC CO (JP) 2001-02-28 CN disclosed
EP-0857712-A1 Process for the preparation of malonic and alkylmalonic acids HÜLS AKTIENGESELLSCHAFT (DE) 1998-08-12 EP disclosed
CN-1010938-B Purification of 1, 2-ethylene glycol from ethylene carbonate SCIENCE DESIGN CO LTD (US) 1990-12-26 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12630492-B2 Cannabinoid derivatives CNR2, CNR1, OPRM1 TSHR 2372/4885TP53 4879/4885HCAR2 177/4885
US-20220267239-A1 CANNABINOID DERIVATIVES CNR2, CNR1, TRPV1 TSHR 1453/4885TP53 4238/4885HCAR2 86/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.